Impact of regular LDL apheresis on the development of restless legs syndrome

Movement Disorders

Volumn 19, Issue 9, 2004, Pages 1072-1075

  Tings, Tobias ^a   Schettler, Volker ^a   Canelo, Monica ^a   Paulus, Walter ^a   Trenkwalder, Claudia ^a  

^a UNIVERSITY OF GÖTTINGEN   (Germany)

Author keywords

Hyperlipidaemia; Iron metabolism; LDL apheresis; Restless legs syndrome

Indexed keywords

DOPAMINE RECEPTOR STIMULATING AGENT; IRON; LEVODOPA; LOW DENSITY LIPOPROTEIN;

ADOLESCENT; ADULT; AGED; APHERESIS; ARTICLE; CLINICAL ARTICLE; COMORBIDITY; CONTROLLED STUDY; FEMALE; HUMAN; HYPERLIPIDEMIA; IRON DEFICIENCY; IRON METABOLISM; ISCHEMIC HEART DISEASE; MALE; PATHOGENESIS; PRIORITY JOURNAL; RESTLESS LEGS SYNDROME; SCHOOL CHILD;

ADULT; ANEMIA, IRON-DEFICIENCY; BLOOD COMPONENT REMOVAL; C-REACTIVE PROTEIN; FEMALE; FERRITINS; HUMANS; HYPERLIPIDEMIAS; MALE; MIDDLE AGED; RESTLESS LEGS SYNDROME; SEVERITY OF ILLNESS INDEX; TRANSFERRIN;

EID: 4644369293     PISSN: 08853185     EISSN: None     Source Type: Journal    
DOI: 10.1002/mds.20102     Document Type: Article

References (5)

1. Schettler V, Wieland E, Armstrong VW, Kleinoeder T, Grunewald RW, Muller GA, Participants of the Gottingen Consensus Conferences. First steps toward the establishment of a German low-density lipoprotein-apheresis registry: recommendations for the indication and for quality management. Ther Apher 2002;6:381-383.
2. Walters AS. Toward a better definition of the restless legs syndrome. The International Restless Legs Syndrome Study Group. Mov Disord 1995;10:634-642.
3. Hening W, et al. The International RLS Study Group Rating Scale: a reliable and valid instrument for assessing severity of the restless legs syndrome. Neurology 2001;56(Suppl.):4.
4. Allen RP, Earley CJ. Restless legs syndrome: a review of clinical and pathophysiologic features. J Clin Neuropohysiol 2001;18:128-147.
5. Berger GM, Firth JC, Jacobs P, Wood L, Marais AD, Horak A. Three different schedules of low-density lipoprotein apheresis compared with plasmapheresis in patients with homozygous familial hypercholesterolemia. Am J Med 1990;88:94-100.